Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers

A. Lochmanová, J. Martinek, H. Tomášková, H. Zelená, K. Dieckmann, E. Grage-Griebenow, E. Ježo, J. Janošek

. 2023 ; 13 (4) : . [pub] 20230208

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23002969

Cellular immunity against SARS-CoV-2 is an important component of the immune response to the virus. At present, two such tests based on interferon-gamma release (interferon-γ release assays, IGRAs) are available-Quan-T-Cell SARS-CoV-2 by EUROIMMUN and T-SPOT.COVID by Oxford Immunotec. In this paper, we compared the results of these two tests in 90 subjects employed at the Public Health Institute Ostrava who had previously undergone COVID-19 infection or were vaccinated against that disease. To the best of our knowledge, this is the first head-to-head comparison of these two tests evaluating T-cell-mediated immunity against SARS-CoV-2. In addition, we also evaluated humoral immunity in the same individuals using the in-house virus neutralization test and IgG ELISA assay. The evaluation yielded similar results for both IGRAs, with Quan-T-Cell appearing to be insignificantly (p = 0.08) more sensitive (all 90 individuals were at least borderline positive) than T-SPOT.COVID (negative results found in five patients). The overall qualitative (presence/absence of immune response) agreement of both tests with virus neutralization test and anti-S IgG was also excellent (close or equal to 100% in all subgroups, with the exception of unvaccinated Omicron convalescents, a large proportion of whom, i.e., four out of six subjects, were IgG negative while at least borderline positive for T-cell-mediated immunity measured by Quan-T). This implies that the evaluation of T-cell-mediated immunity is a more sensitive indicator of immune response than the evaluation of IgG seropositivity. This is true at least for unvaccinated patients with a history of being infected only by the Omicron variant, but also likely for other groups of patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002969
003      
CZ-PrNML
005      
20230421100059.0
007      
ta
008      
230413s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/diagnostics13040637 $2 doi
035    __
$a (PubMed)36832126
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Lochmanová, Alexandra $u Public Health Institute Ostrava, 70200 Ostrava, Czech Republic $u Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic
245    10
$a Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers / $c A. Lochmanová, J. Martinek, H. Tomášková, H. Zelená, K. Dieckmann, E. Grage-Griebenow, E. Ježo, J. Janošek
520    9_
$a Cellular immunity against SARS-CoV-2 is an important component of the immune response to the virus. At present, two such tests based on interferon-gamma release (interferon-γ release assays, IGRAs) are available-Quan-T-Cell SARS-CoV-2 by EUROIMMUN and T-SPOT.COVID by Oxford Immunotec. In this paper, we compared the results of these two tests in 90 subjects employed at the Public Health Institute Ostrava who had previously undergone COVID-19 infection or were vaccinated against that disease. To the best of our knowledge, this is the first head-to-head comparison of these two tests evaluating T-cell-mediated immunity against SARS-CoV-2. In addition, we also evaluated humoral immunity in the same individuals using the in-house virus neutralization test and IgG ELISA assay. The evaluation yielded similar results for both IGRAs, with Quan-T-Cell appearing to be insignificantly (p = 0.08) more sensitive (all 90 individuals were at least borderline positive) than T-SPOT.COVID (negative results found in five patients). The overall qualitative (presence/absence of immune response) agreement of both tests with virus neutralization test and anti-S IgG was also excellent (close or equal to 100% in all subgroups, with the exception of unvaccinated Omicron convalescents, a large proportion of whom, i.e., four out of six subjects, were IgG negative while at least borderline positive for T-cell-mediated immunity measured by Quan-T). This implies that the evaluation of T-cell-mediated immunity is a more sensitive indicator of immune response than the evaluation of IgG seropositivity. This is true at least for unvaccinated patients with a history of being infected only by the Omicron variant, but also likely for other groups of patients.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Martinek, Jan $u Public Health Institute Ostrava, 70200 Ostrava, Czech Republic $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic $1 https://orcid.org/0000000168697391
700    1_
$a Tomášková, Hana $u Public Health Institute Ostrava, 70200 Ostrava, Czech Republic $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic $1 https://orcid.org/0000000296081276 $7 pna2008424773
700    1_
$a Zelená, Hana $u Public Health Institute Ostrava, 70200 Ostrava, Czech Republic
700    1_
$a Dieckmann, Kersten $u Institute for Experimental Immunology, Affiliated to EUROIMMUN Medizinische Labordiagnostik AG, 23560 Lübeck, Germany
700    1_
$a Grage-Griebenow, Evelin $u Institute for Experimental Immunology, Affiliated to EUROIMMUN Medizinische Labordiagnostik AG, 23560 Lübeck, Germany
700    1_
$a Ježo, Eduard $u Public Health Institute Ostrava, 70200 Ostrava, Czech Republic
700    1_
$a Janošek, Jaroslav $u Center for Health Research, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic $1 https://orcid.org/0000000306824521
773    0_
$w MED00195450 $t Diagnostics (Basel, Switzerland) $x 2075-4418 $g Roč. 13, č. 4 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36832126 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20230421100052 $b ABA008
999    __
$a ok $b bmc $g 1922727 $s 1189176
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 13 $c 4 $e 20230208 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
LZP    __
$a Pubmed-20230413

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace